GENESIS DIAGNOSTICS Trademark

Trademark Overview

On Thursday, February 6, 2020, a trademark application was filed for GENESIS DIAGNOSTICS with the United States Patent and Trademark Office. The USPTO has given the GENESIS DIAGNOSTICS trademark a serial number of 88787323. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 11, 2023. This trademark is owned by Abira Medical Laboratories, LLC. The GENESIS DIAGNOSTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical laboratory services, namely, screening, diagnostic, toxicology, as well as clinical and anatomic pathology services, specifically excluding genetic research, cell research, and development of new drugs
genesis diagnostics

General Information

Serial Number88787323
Word MarkGENESIS DIAGNOSTICS
Filing DateThursday, February 6, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of an image of a crescent moon which opens to the right with a structure of double-stranded dna with the word "GENESIS" to the right of the image and the word "DIAGNOSTICS" underneath "GENESIS".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"DIAGNOSTICS"
Goods and ServicesMedical laboratory services, namely, screening, diagnostic, toxicology, as well as clinical and anatomic pathology services, specifically excluding genetic research, cell research, and development of new drugs

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 10, 2020
Primary Code042
First Use Anywhere DateTuesday, April 14, 2015
First Use In Commerce DateTuesday, April 14, 2015

Trademark Owner History

Party NameAbira Medical Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLanghorne, PA 19047

Trademark Events

Event DateEvent Description
Tuesday, April 11, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 11, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, December 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 10, 2022NON-FINAL ACTION E-MAILED
Saturday, December 10, 2022NON-FINAL ACTION WRITTEN
Sunday, May 15, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, November 14, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 11, 2021WITHDRAWAL OF ATTORNEY GRANTED
Monday, October 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, October 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 13, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 9, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 8, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 8, 2020LETTER OF SUSPENSION E-MAILED
Friday, May 8, 2020SUSPENSION LETTER WRITTEN
Wednesday, April 29, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, April 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 29, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, April 29, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, April 27, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2020NEW APPLICATION ENTERED

Related Keywords

diagnostics genesis research services genetic excluding specifically cell drugs development pathology clinical